Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strategy.
Shlay JC, Bartsch G, Peng G, Wang J, Grunfeld C, Gibert CL, Visnegarwala F, Raghavan SS, Xiang Y, Farrough M, Perry HE, Kotler D, El-Sadr WM. Shlay JC, et al. J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):506-17. doi: 10.1097/QAI.0b013e31804216cf. J Acquir Immune Defic Syndr. 2007. PMID: 17325603 Clinical Trial.
The effect of individual antiretroviral drugs on body composition in HIV-infected persons initiating highly active antiretroviral therapy.
Shlay JC, Sharma S, Peng G, Gibert CL, Grunfeld C; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA); International Network for Strategic Initiatives in Global HIV Trials (INSIGHT). Shlay JC, et al. J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):298-304. doi: 10.1097/QAI.0b013e3181aa1308. J Acquir Immune Defic Syndr. 2009. PMID: 19412117 Free PMC article. Clinical Trial.
Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine.
Shlay JC, Visnegarwala F, Bartsch G, Wang J, Peng G, El-Sadr WM, Gibert C, Kotler D, Grunfeld C, Raghavan S; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Shlay JC, et al. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):147-55. doi: 10.1097/01.qai.0000143599.64234.15. J Acquir Immune Defic Syndr. 2005. PMID: 15671799 Clinical Trial.
Racial differences in changes of metabolic parameters and body composition in antiretroviral therapy-naive persons initiating antiretroviral therapy.
Gibert CL, Shlay JC, Sharma S, Bartsch G, Peng G, Grunfeld C; Terry Beirn Community Programs for Clinical Research on AIDS; International Network for Strategic Initiatives in Global HIV Trials. Gibert CL, et al. Among authors: shlay jc. J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):44-53. doi: 10.1097/QAI.0b013e31818ce808. J Acquir Immune Defic Syndr. 2009. PMID: 19295334
Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial.
Burman W, Grund B, Neuhaus J, Douglas J Jr, Friedland G, Telzak E, Colebunders R, Paton N, Fisher M, Rietmeijer C; SMART Study Group and INSIGHT. Burman W, et al. J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):142-50. doi: 10.1097/QAI.0b013e318183a9ad. J Acquir Immune Defic Syndr. 2008. PMID: 18769356 Free PMC article. Clinical Trial.
Continuous antiretroviral therapy decreases bone mineral density.
Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, Martinez E, Reiss P, Visnegarwala F, Carr AD; INSIGHT SMART Body Composition Substudy Group. Grund B, et al. Among authors: shlay jc. AIDS. 2009 Jul 31;23(12):1519-29. doi: 10.1097/QAD.0b013e32832c1792. AIDS. 2009. PMID: 19531929 Free PMC article. Clinical Trial.
62 results